Petra Krabisch Selected Research

Petra Krabisch Research Topics

16	Breast Neoplasms (Breast Cancer) 12/2023 - 02/2012
7	Neoplasms (Cancer) 11/2023 - 02/2012
3	Neutropenia 02/2021 - 07/2013
2	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 01/2018
2	Infections 02/2021 - 07/2013
2	Thrombocytopenia (Thrombopenia) 01/2018 - 07/2013
1	Pathologic Complete Response 01/2023
1	Febrile Neutropenia 02/2021
1	Musculoskeletal Pain 10/2019
1	Arthralgia (Joint Pain) 10/2019
1	Pain (Aches) 10/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2018
1	Ascites 01/2018
1	Fever (Fevers) 01/2018
1	Alopecia (Baldness) 01/2018
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Pulmonary Embolism 01/2018
1	Cachexia 01/2018
1	Disease Progression 01/2018
1	Sepsis (Septicemia) 01/2018
1	Inflammation (Inflammations) 07/2013
1	Exanthema (Rash) 07/2013
1	Circulating Neoplastic Cells 02/2012

4	Hormones (Hormone)IBA 12/2023 - 04/2019
2	Letrozole (Femara)FDA LinkGeneric 12/2023 - 10/2019
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2016
2	Bevacizumab (Avastin)FDA Link 01/2019 - 07/2013
2	Epirubicin (Ellence)FDA LinkGeneric 01/2019 - 07/2013
2	AnthracyclinesIBA 01/2019 - 01/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 07/2013
1	ribociclibIBA 12/2023
1	Epidermal Growth Factor (EGF)IBA 12/2023
1	130-nm albumin-bound paclitaxelIBA 01/2023
1	Denosumab FDA Link 01/2023
1	pegfilgrastim (Neulasta)FDA Link 02/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2020
1	Aromatase InhibitorsIBA 10/2019
1	eribulin FDA Link 01/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Carbonic Anhydrase IXIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	PlatinumIBA 01/2018
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2013
1	Everolimus FDA Link 07/2013
1	taxaneIBA 01/2013
1	Messenger RNA (mRNA)IBA 02/2012
1	AntibodiesIBA 02/2012